Pharmaceutical formulations containing methylnaltrexone

Details for Australian Patent Application No. 2004229463 (hide)

Owner Progenics Pharmaceuticals. Inc.

Inventors Sanghvi, Suketu P.; Boyd, Thomas A.

Agent Davies Collison Cave

Pub. Number AU-B-2004229463

PCT Pub. Number WO2004/091623

Priority 60/461,611 08.04.03 US

Filing date 8 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 22 July 2010

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/047 (2006.01)

A61K 31/195 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/091623 Priority application(s): WO2004/091623

22 July 2010 Application Accepted

  Published as AU-B-2004229463

18 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229464-Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist

2004229462-The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome